4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post program implementation

dc.contributor.authorWang, B.
dc.contributor.authorGiles, L.
dc.contributor.authorAndraweera, P.
dc.contributor.authorMcMillan, M.
dc.contributor.authorAlmond, S.
dc.contributor.authorBeazley, R.
dc.contributor.authorMitchell, J.
dc.contributor.authorAHoure, M.
dc.contributor.authorDenehy, E.
dc.contributor.authorFlood, L.
dc.contributor.authorMarshall, H.
dc.date.issued2023
dc.descriptionPublished online: May 31, 2023
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityBing Wang, Lynne Giles, Prabha Andraweera, Mark McMillan, Sara Almond, Rebecca Beazley, Janine Mitchell, Michele Ahoure, Emma Denehy, Louise Flood, Helen Marshall
dc.identifier.citationJournal of Infection, 2023; 87(2):95-102
dc.identifier.doi10.1016/j.jinf.2023.05.021
dc.identifier.issn0163-4453
dc.identifier.issn1532-2742
dc.identifier.orcidWang, B. [0000-0003-2445-2952]
dc.identifier.orcidGiles, L. [0000-0001-9054-9088]
dc.identifier.orcidAndraweera, P. [0000-0003-2434-8370]
dc.identifier.orcidMcMillan, M. [0000-0002-6490-7707]
dc.identifier.orcidMarshall, H. [0000-0003-2521-5166]
dc.identifier.urihttps://hdl.handle.net/2440/138810
dc.language.isoen
dc.publisherElsevier
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1155066
dc.rights© 2023 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
dc.source.urihttps://www.sciencedirect.com/science/article/pii/S0163445323003006
dc.subject4CMenB; Vaccine effectiveness; Vaccine impact
dc.title4CMenB sustained vaccine effectiveness against invasive meningococcal B disease and gonorrhoea at three years post program implementation
dc.typeJournal article
pubs.publication-statusPublished

Files